AXL in cancer: a modulator of drug resistance and therapeutic target

被引：53

作者：

Tang, Yaoxiang ^{[1
]}

Zang, Hongjing ^{[1
]}

Wen, Qiuyuan ^{[1
]}

Fan, Songqing ^{[1
]}

机构：

[1] Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha 410011, Hunan, Peoples R China

来源：

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | 2023年 / 42卷 / 01期

基金：

中国国家自然科学基金;

关键词：

AXL; Cancer; Drug resistance; Target therapy; Molecular mechanisms; RECEPTOR TYROSINE KINASE; EPITHELIAL-MESENCHYMAL TRANSITION; CELL LUNG-CANCER; ACQUIRED-RESISTANCE; BREAST-CANCER; DNA-DAMAGE; GAS6/AXL AXIS; EGFR-TKI; INHIBITION; PROMOTES;

D O I：

10.1186/s13046-023-02726-w

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

AXL is a member of the TAM (TYRO3, AXL, and MERTK) receptor tyrosine kinases family (RTKs), and its abnormal expression has been linked to clinicopathological features and poor prognosis of cancer patients. There is mounting evidence supporting AXL's role in the occurrence and progression of cancer, as well as drug resistance and treatment tolerance. Recent studies revealed that reducing AXL expression can weaken cancer cells' drug resistance, indicating that AXL may be a promising target for anti-cancer drug treatment. This review aims to summarize the AXL's structure, the mechanisms regulating and activating it, and its expression pattern, especially in drug-resistant cancers. Additionally, we will discuss the diverse functions of AXL in mediating cancer drug resistance and the potential of AXL inhibitors in cancer treatment.

引用

页数：14

共 113 条

[1] Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer [J].

Adam-Artigues, Anna ;

Arenas, Enrique J. ;

Martinez-Sabadell, Alex ;

Braso-Maristany, Fara ;

Cervera, Raimundo ;

Tormo, Eduardo ;

Hernando, Cristina ;

Teresa Martinez, Maria ;

Carbonell-Asins, Juan ;

Simon, Soraya ;

Poveda, Jesus ;

Moragon, Santiago ;

Zazo, Sandra ;

Martinez, Debora ;

Rovira, Ana ;

Burgues, Octavio ;

Rojo, Federico ;

Albanell, Joan ;

Bermejo, Begona ;

Lluch, Ana ;

Prat, Aleix ;

Arribas, Joaquin ;

Eroles, Pilar ;

Miguel Cejalvo, Juan .

SCIENCE ADVANCES, 2022, 8 (20)

[2] Reprogramming the immunological microenvironment through radiation and targeting Axl [J].

Aguilera, Todd A. ;

Rafat, Marjan ;

Castellini, Laura ;

Shehade, Hussein ;

Kariolis, Mihalis S. ;

Hui, Angela Bik-Yu ;

Stehr, Henning ;

von Eyben, Rie ;

Jiang, Dadi ;

Ellies, Lesley G. ;

Koong, Albert C. ;

Diehn, Maximilian ;

Rankin, Erinn B. ;

Graves, Edward E. ;

Giaccia, Amato J. .

NATURE COMMUNICATIONS, 2016, 7

[3] Nanomedicine tactics in cancer treatment: Challenge and hope [J].

Al-Zoubi, Mazhar Salim ;

Al-Zoubi, Raed M. .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 174

[4] The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer [J].

Antony, Jane ;

Tan, Tuan Zea ;

Kelly, Zoe ;

Low, Jeffrey ;

Choolani, Mahesh ;

Recchi, Chiara ;

Gabra, Hani ;

Thiery, Jean Paul ;

Huang, Ruby Yun-Ju .

SCIENCE SIGNALING, 2016, 9 (448)

[5] AXL Receptor in Cancer Metastasis and Drug Resistance: When Normal Functions Go Askew [J].

Auyez, Almira ;

Sayan, A. Emre ;

Kriajevska, Marina ;

Tulchinsky, Eugene .

CANCERS, 2021, 13 (19)

[6] Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy [J].

Badarni, Mai ;

Prasad, Manu ;

Balaban, Noa ;

Zorea, Jonathan ;

Yegodayev, Ksenia M. ;

Ben-Zion, Joshua ;

Dinuri, Anat Bahat ;

Grenman, Reidar ;

Rotblatc, Barak ;

Cohen, Limor ;

Elkabets, Moshe .

JCI INSIGHT, 2019, 4 (08)

[7] Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance [J].

Bagchi, Sreya ;

Yuan, Robert ;

Engleman, Edgar G. .

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021, 2021, 16 :223-249

[8] Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site [J].

Braunger, J ;

Schleithoff, L ;

Schulz, AS ;

Kessler, H ;

Lammers, R ;

Ullrich, A ;

Bartram, CR ;

Janssen, JWG .

ONCOGENE, 1997, 14 (22) :2619-2631

[9] Cross-Phosphorylation, Signaling and Proliferative Functions of the Tyro3 and Axl Receptors in Rat2 Cells [J].

Brown, Jessica E. ;

Krodel, Meredith ;

Pazos, Mauricio ;

Lai, Cary ;

Prieto, Anne L. .

PLOS ONE, 2012, 7 (05)

[10] GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis [J].

Bruce, Shaina F. ;

Cho, Kevin ;

Noia, Hollie ;

Lomonosova, Elena ;

Stock, Elizabeth C. ;

Oplt, Alyssa ;

Blachut, Barbara ;

Mullen, Mary M. ;

Kuroki, Lindsay M. ;

Hagemann, Andrea R. ;

McCourt, Carolyn K. ;

Thaker, Premal H. ;

Khabele, Dineo ;

Powell, Matthew A. ;

Mutch, David G. ;

Shriver, Leah P. ;

Patti, Gary J. ;

Fuh, Katherine C. .

MOLECULAR CANCER THERAPEUTICS, 2022, 21 (08) :1348-1359

← 1 2 3 4 5 6 7 8 9 10 →